United Therapeutics | UTHR - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Amarin USD -852K 7.26M 2025-12
Ardelyx USD -37.6M 37.2M 2026-03
Baxter International USD -6M 750M 2026-03
Bayer EUR -3.37B 2.21B 2025-12
BioCryst Pharmaceuticals USD 248.02M 235.89M 2025-12
Biogen USD 647.3M 269.6M 2026-06
BioMarin Pharmaceutical USD 141.2M 168.36M 2026-03
Gilead Sciences USD 2.08B 1.56B 2025-12
GlaxoSmithKline GBP 2.68B 532M 2026-06
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Insmed USD -162.1M 164.84M 2026-03
Ionis Pharmaceuticals USD -114M 21M 2026-06
J&J USD 8.66B 839M 2026-06
Lexicon Pharmaceuticals USD -12.77M 16.02M 2025-09
Moderna USD -799M 612M 2025-12
Omeros USD -65.12M 21.27M 2024-06
Pfizer USD 5.18B 6.82B 2026-03
PTC Therapeutics USD -2.46M 136.62M 2026-03
Regeneron Pharmaceuticals USD 831.2M 212.5M 2026-03
Sangamo BioSciences USD -36.05M 12.94M 2024-06
Sarepta Therapeutics USD 343.17M 750.85M 2026-03
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
United Therapeutics USD 444M 6M 2025-12
Vertex Pharmaceuticals USD 1.25B 78.1M 2026-03